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INTRAMYOCARDIAL BONE MARROW CELL INJECTION  
FOR ISCHEMIC HEART DISEASE:  
EFFICACY ANALYSIS AND LONG TERM FOLLOW-UP
1. Intramyocardial injection of bone marrow-derived mononuclear cells is a safe and long lasting effective 
treatment strategy for refractory angina patient with chronic myocardial ischemia (this thesis)
2. Repeated bone marrow cell injection is an effective treatment strategy for patients with progressive 
obstructive coronary artery disease and angina symptoms who have responded successfully to previous 
bone marrow cell treatment (this thesis)
3. Long-term mortality in patients with refractory angina who are not candidates for traditional 
revascularization is surprisingly low, therefore therapeutic options for this growing population should 
focus on chest pain relief and improved quality of life (derived from Timothy D. Henry, European Heart 
Journal, 2013)
4. As intramyocardial bone marrow cell injection seems to decrease angina-related emergency room visits, 
hospital admissions and in-hospital procedures, this treatment could result in a significant reduction of 
healthcare costs of refractory angina (this thesis)
5. Refractory angina patients with chronic myocardial ischemia who are diabetics and patients with a large 
number of ischemic segments benefit most from intramyocardial bone marrow cell treatment (this thesis)
6. Although cautious persons may argue that we first have to fully understand the biology of cell therapy 
and the mechanisms underlying the putative benefits before pursuing further clinical studies, the field 
of cell therapy, more than any other field, needs translational studies and a close forward-and-reverse 
interaction between bench and bedside (Emmanouil Chavakis, Circulation, 2010)
7. Treatments designed to improve stem cell homing to diseased myocardium have the potential to markedly 
enhance both the safety and efficacy of cardiovascular cell therapy (Schoenhard, Journal of Cardiovascular 
Translational Research, 2009)
8. It’s easy to be excited about stem cell research (Deborah J. Sweet, Cell Stem Cell, 2007)
9. Medical science has made such tremendous progress that there is hardly a healthy human left  
(Aldous Huxley, 1946)
10. Always laugh when you can. It is cheap medicine (Lord Byron, 1788 - 1824)
11. Sometimes a cigar is just a cigar (Sigmund Freud, ±1920)
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